KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Times Interest Earned (2019 - 2025)

Historic Times Interest Earned for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to $5.37.

  • Royalty Pharma's Times Interest Earned fell 5142.65% to $5.37 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.49, marking a year-over-year decrease of 2640.84%. This contributed to the annual value of $5.73 for FY2024, which is 2810.39% down from last year.
  • Latest data reveals that Royalty Pharma reported Times Interest Earned of $5.37 as of Q3 2025, which was down 5142.65% from $3.06 recorded in Q2 2025.
  • Royalty Pharma's 5-year Times Interest Earned high stood at $19.9 for Q2 2021, and its period low was -$10.28 during Q4 2022.
  • In the last 5 years, Royalty Pharma's Times Interest Earned had a median value of $5.5 in 2024 and averaged $5.86.
  • Per our database at Business Quant, Royalty Pharma's Times Interest Earned plummeted by 41473.06% in 2022 and then soared by 59075.96% in 2025.
  • Royalty Pharma's Times Interest Earned (Quarter) stood at $3.27 in 2021, then crashed by 414.73% to -$10.28 in 2022, then surged by 226.18% to $12.97 in 2023, then plummeted by 57.61% to $5.5 in 2024, then dropped by 2.34% to $5.37 in 2025.
  • Its last three reported values are $5.37 in Q3 2025, $3.06 for Q2 2025, and $8.19 during Q1 2025.